Oslo, Norway – 26 November 2024. Following the private placement on 16. September 2024 (the “Private Placement”), IDEX Biometrics ASA (the “Company”) is conducting a subsequent offering (repair issue) of up to 140 million shares at NOK 0.15 per share. Shareholders who participate in this offering will also receive warrants to subscribe for additional shares at the same price (NOK 0.15 per share). Deadline for subscription is 29 November 2024 at 16:30 CET. For more information and a link to the subscription ...

Oslo, Norway, and Seoul, South Korea 19 November 2024 – IDEX Biometrics has entered into a commercial development agreement with South Korean smart card manufacturer Cellfie Global (formerly ICK) to design, manufacture and market biometric metal and PVC cards for bank and fintech launches in USA, Europe and Asia. This gives IDEX Biometrics full coverage across all four card manufacturers in South Korea, representing a production capacity in excess of 100 million smart cards annually, and with world leading ...

Reference is made to the stock exchange announcement issued by IDEX Biometrics ASA (the “Company”) on 17 September 2024 regarding the successful private placement of 466,666,666 new shares (“Private Placement” and the “Private Placement Shares”), and the possible subsequent offering of up to 140,000,000 new shares (“Subsequent Offering” and the “Subsequent Offering Shares”). As stated in the announcement on 17 September 2024, the listing of the Private Placement Shares and the offering and listing of the Su ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________ Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-10235 IDEX CORPORATION (Exact name of registrant as specified in its charter) Delaware 36-3555336 (State o ...

IDEX Corporation (NYSE:IEX) Q3 2024 Earnings Conference Call October 30, 2024 10:30 AM ET Company Participants Wendy Palacios - Vice President, Investor Relations, FP&A Eric Ashleman - Chief Executive Officer & President Abhi Khandelwal - Senior Vice President & Chief Financial Officer Conference Call Participants Deane Dray - RBC Capital Markets Nathan Jones - Stifel Mike Halloran - Baird Vlad Bystricky - Citigroup Jeff Sprague - Vertical Research Partners Andrew Buscaglia - BNP Paribas Brett Linzey - Mizu ...

| --- | --- | --- | --- | |----------------------------------------------|-------|-------|-------| | Click Here to Edit Title | | | | | | | | | | Third Quarter 2024 Earnings October 30, 2024 | | | | | | | | | Trusted Solutions, Improving Lives™ Cautionary Statement Click Here to Edit Title 2 Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 19 ...

For further information: TRADED: NYSE (IEX) EX-99.1 Investor Contact: Wendy Palacios Vice President FP&A and Investor Relations (847) 498-7070 IDEX REPORTS THIRD QUARTER RESULTS Third Quarter 2024 Highlights (All comparisons are against the third quarter of 2023 unless otherwise noted) • Sales of $798 million, up 1% overall and flat organically • Reported diluted EPS of $1.57, down 43%, and adjusted diluted EPS of $1.90, down 10% • Operating cash flow of $205 million, down 9%; and 172% of net income, up fro ...

IDEX Corporation's (IEX) third-quarter 2024 adjusted earnings of $1.90 per share surpassed the Zacks Consensus Estimate of $1.89. The bottom line decreased approximately 10.4% from the year-ago quarter's earnings of $2.12. However, it matched the upper band of the management's projected range of $1.85-$1.90 per share. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. IEX's Revenue Details IDEX's net sales of $798.2 million beat the Zacks Consensus Estimate of $791 million. The top li ...

For the quarter ended September 2024, Idex (IEX) reported revenue of $798.2 million, up 0.6% over the same period last year. EPS came in at $1.90, compared to $2.12 in the year-ago quarter. The reported revenue represents a surprise of +0.92% over the Zacks Consensus Estimate of $790.95 million. With the consensus EPS estimate being $1.89, the EPS surprise was +0.53%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expec ...

Idex (IEX) came out with quarterly earnings of $1.90 per share, beating the Zacks Consensus Estimate of $1.89 per share. This compares to earnings of $2.12 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 0.53%. A quarter ago, it was expected that this maker of the Jaws of Life device and other engineered products would post earnings of $2.04 per share when it actually produced earnings of $2.06, delivering a surprise of 0.98% ...